HUMA
Humacyte, Inc. · Healthcare
Director Brady W Dougan sold $6.4M of Humacyte, Inc.
Sold$6,378,837
$3.54Price
1,799,596Shares
−15%Stake
What HUMA did after the filing
- The stock from Mon, Aug 21 close, $3.37
- −18.4%
- S&P 500, same days
- −3.7%
Measured over 30 trading days, to the Oct 3 close.
Traded Thu, Aug 17. Filed Mon, Aug 21, 2:07 PM ET, during the session. Returns use the Aug 21 close and the Oct 3 close. Not investment advice.